• Cross Country Healthcare posted Q1 2026 revenue of USD 241.1 million, down 18% year over year, with net loss attributable to common stockholders widening to USD 4.3 million.
• Diluted EPS was a loss of USD 0.14, swinging from a profit of USD 2.42 in Q4 2025.
• Adjusted EBITDA was USD 3.9 million, down 55% year over year, with gross profit margin at 19.7%.
• Nurse and Allied Staffing revenue rose 4% sequentially to USD 201.4 million, while Physician Staffing revenue fell 7% sequentially to USD 39.6 million.
• Signed 4 new MSP/VMS agreements, licensed Intellify to a top-10 healthcare staffing provider, repurchased 650,000 shares, ended quarter with USD 105.6 million in cash and no debt; Kevin C. Clark said focus remains on execution and technology initiatives ahead of pending Knox Lane transaction expected to close in Q3.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cross Country Healthcare Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202605071615BIZWIRE_USPR_____20260507_BW508743) on May 07, 2026, and is solely responsible for the information contained therein.